FIELD: medicine.
SUBSTANCE: invention relates to a method for treatment of cerebral ischemia on its model in mammal. Method involves administration in mammal the effective doses of bis-[(2-hydroxyethyl)-N,N,N-trimethylaminium] succinate. This provides prophylaxis of development of unfavorable results of cerebral ischemia and/or insult based on prevention of cerebral neurons death, reducing rate of pathological decreasing the energetic metabolism in ischemia being without by-side effects.
EFFECT: improved and enhanced method of treatment of cerebral ischemia.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMPROVING COGNITIVE FUNCTION | 2005 |
|
RU2281766C1 |
| BIS-(2=HYDROXY-N,N,N-TRIMETHYLETHANEAMINIUM) SUCCINATE FOR TREATMENT OF INSULIN RESISTANCE, DIABETES MELLITUS, HYPERLIPIDEMIA AND DYSLIPIDEMIA | 2000 |
|
RU2228174C2 |
| COMPOSITIONS AND METHODS FOR POTENTIATING THERAPEUTIC EFFECTS OF INTERFERONS | 2001 |
|
RU2242243C2 |
| METHOD FOR PREVENTION OF BRAIN ISCHEMIA | 2017 |
|
RU2642961C1 |
| APPLICATION OF WATER WITH LOWERED CONTENT OF DEUTERIUM FOR PREPARATION OF AGENTS OF TREATMENT OF NEURODEGENERATIVE DISEASES AND IMPROVEMENT OF COGNITIVE FUNCTION | 2007 |
|
RU2338542C1 |
| USE OF CHOLINE SALT OF SUCCINIC ACID IN PRODUCTION OF AGENTS FOR TREATING CRANIOCEREBRAL INJURY | 2018 |
|
RU2689384C1 |
| USE OF CHOLINE SALT OF SUCCINCIC ACID IN PRODUCTION OF MEDICINAL PRODUCT FOR TREATMENT OF BRAIN INFARCTION | 2023 |
|
RU2806828C1 |
| CHOLINE SALT FUMARIC ACID | 2017 |
|
RU2672728C1 |
| METHOD FOR TREATING PATIENTS FOR NEOPLASMS | 2005 |
|
RU2275920C1 |
| INTRANASAL PHARMACEUTICAL COMPOSITION BASED ON INSULIN | 2016 |
|
RU2619855C1 |
